With the emergence and long-term Impact of COVID-19, the Global Animal Model Market is to reach USD XX Billion by 2030
Bizwit Research & Consulting LLP’s Recent Analysis on Global Animal Model Market is poised to raise up to USD XX Billion by 2030. An animal model refers to a living organism, typically an animal, used in scientific research to simulate and study biological and pathological processes, as well as to understand and investigate various aspects of human health and disease. Animal models serve as experimental systems that mimic certain aspects of human physiology, anatomy, genetics, and behavior, allowing scientists to observe and manipulate these systems in controlled laboratory settings.
Animal models are employed across various disciplines, including biomedical research, drug development, genetics, toxicology, and behavioral studies, to gain insights into fundamental biological processes, test hypotheses, evaluate treatments, and advance scientific knowledge. The Animal Model Market is growing because of factors such as increasing preclinical trials, increasing adoption of CRISPR technology and growing investments in R&D of the pharmaceutical industry. According to Statista, globally, the R&D spending in the pharmaceutical industry reached approximately USD 238 billion in 2021. The growing rate of preclinical trials is also helping in driving the market growth.
According to the World Health Organization (WHO) report in February 2022, there were 47,689 registered preclinical trial studies conducted in 2021. This significant increase in the number of preclinical studies indicates a growing demand for animal models in research. Moreover, advancements in genetic engineering and genome editing techniques may create lucrative opportunities for the market. However, high research costs and growing criticism on animal testing by several organizations stifles market growth throughout the forecast period of 2023-2030.
Geographically, the global Animal Model Market has been segmented into North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa (MEA). North America dominated the market in 2022 with the largest market share owing to factors such as the presence of key industry players, increasing biomedical research in the United States, and the growing preclinical activities conducted by clinical research organizations (CROs) and pharmaceutical companies in the region.
However, Asia Pacific is expected to grow significantly during the forecast period, owing to an increase in government initiatives and investments in drug research utilizing animal models, the growing significance of mouse clinical trials (MCTs) for improved outcome projections, ongoing innovations in animal models, the availability of advanced healthcare systems, and a substantial surge in demand for advanced healthcare facilities.
The global Animal Model Market is highly competitive owing to the presence of several key manufacturers such as Biocytogen Pharmaceuticals Co. Ltd, Labcorp UK Limited (Envigo Rms Inc.), Hera Testing Laboratories, Charles River Laboratories International Inc., The Jackson Laboratory, Harbour BioMed Co. Ltd, and others.
For further analysis on this or to request a sample copy of this report, please click the link mentioned below:
Key findings of the study suggest:
- Global Animal Model Market is anticipated to grow with a healthy growth rate of more than 8.6% over the forecast period 2023-2030.
- In the Animal Type segment, mice emerged as the leading market segment in 2022.
- North America is anticipated to drive regional growth owing to a surge in a number of preclinical activities conducted by clinical research organizations (CROs) and pharmaceutical companies.
- Asia Pacific is expected to grow at a high CAGR followed by North America during 2023-2030.
Bizwit Research & Consulting has considered the following segments for the study:
By Animal Type:
- Mice
- Birds
- Fish
- Cattle
- Other Animal Types
By Technology:
- CRISPR
- Embryonic Stem Cell Injection
- Nuclear Transfer
- Other Technologies
By Application:
- Oncology
- Cardiovascular
- Neurology
- Other Applications
Regional Outlook
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- ROE
- Asia Pacific
- China
- India
- Japan
- Korea
- Australia
- RoAPAC
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
To get a sample of this report or to purchase a copy of the study, you can directly contact us at: sales@bizwitresearch.com
About Us
Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. The company has a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. Bizwit incorporate big data, expert analysis, and huge industry database to deliver client focused business consulting reports. Our analysts perform unbiased measurement and assessment of market opportunities to comprehend detailed market forecast. Our team of key opinion leaders evaluates the market size, growth prospects, end-use, applications, value & supply chain and top vendors in the industry to help the clients to take conversant business decisions without any vague assumptions.
Contact US
Global Business Development
Phone : +1 209 498-3066
Email: Sales@bizwitresearch.com
Website: www.bizwitresearch.com
